<!doctype html>
<html lang="es">
<head>
<meta charset="utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1" />
<title>Spanish Daily – Dec 12, 2025</title>
<meta name="color-scheme" content="light" />
<style>
  :root { --maxw: 800px; color-scheme: light; }
  html { -webkit-text-size-adjust: 100%; }
  body {
    margin: 0;
    padding: 0;
    background-color: #ffffff;
    color: #111111;
    font-family: system-ui,-apple-system,Segoe UI,Roboto,Helvetica,Arial,sans-serif,Apple Color Emoji,Segoe UI Emoji;
    line-height: 1.6;
    font-size: 18px;
  }
  header, main, footer { max-width: var(--maxw); margin: 0 auto; padding: 16px; }
  header { padding-top: 20px; }
  h1 { font-size: 1.4rem; margin: 0 0 8px; }
  .subtle { opacity: 0.72; font-size: 0.95rem; }
  .card { border: 1px solid rgba(0,0,0,0.08); border-radius: 12px; padding: 14px; margin: 12px 0; }
  .tip-word { all: unset; display: inline; position: relative; cursor: pointer;
    text-decoration: underline dotted; text-underline-offset: 3px;
    padding: 0 .1em; border-radius: .35em; background: rgba(255,235,59,.28); }
  .tooltip { position: fixed; padding: .48rem .6rem; background: rgba(0,0,0,.88); color: #fff;
    border-radius: .55rem; font-size: .95rem; line-height: 1.3; max-width: min(90vw, 26rem);
    z-index: 9999; box-shadow: 0 6px 18px rgba(0,0,0,.18); }
  .content { white-space: pre-line; }
  .card { margin-bottom: 1.5em; line-height: 1.6; }
  strong { display: inline-block; margin-top: .35em; }
  details { border: 1px solid rgba(0,0,0,0.08); border-radius: 12px; padding: 12px; }
  details + details, details + .card { margin-top: 12px; }
  summary { cursor: pointer; font-weight: 600; }
  summary::marker { content: ""; }
  summary::after { content: " ▸"; }
  details[open] summary::after { content: " ▾"; }
  .debug { position: fixed; bottom: 8px; right: 8px; font-size: 12px; opacity: .6; }
</style>
</head>
<body>
  <header>
    <h1>Spanish Daily</h1>
    <div class="subtle">Toca una palabra subrayada para ver la traducción. Toca fuera para cerrar.</div>
  </header>

  <main>
    <!-- Spanish first -->
    <section class="card content">
STORY

En <span title="in">2024–2025</span>, la <span title="vaccine against RSV">vacuna contra el VSR</span> <span title="is mainly aimed at">está dirigida principalmente a</span> los adultos <span title="who benefit the most">que más se benefician</span>. La ACIP en junio de 2024 <span title="gives more details about">da más detalles sobre</span> <span title="who and when to vaccinate">a quién y cuándo vacunar</span> en adultos de <span title="60 years or older">≥60 años</span>.

1. <span title="Clear benefit">Beneficio claro</span>: Los adultos de <span title="75 years or older">≥75 años</span> y los adultos de <span title="60 to 74 years">60–74 años</span> <span title="with at least one high-risk condition">con al menos una condición de alto riesgo</span> <span title="have the best evidence of benefit">tienen la mejor evidencia de beneficio</span> <span title="with one dose of the RSV vaccine">con una dosis de la vacuna contra el VSR</span>. Las <span title="main risk conditions">principales condiciones de riesgo</span> <span title="include">incluyen</span> <span title="chronic lung or heart diseases">enfermedades pulmonares o cardíacas crónicas</span>, <span title="moderate or severe immunosuppression">inmunosupresión moderada o grave</span>, <span title="advanced kidney or liver disease">enfermedad renal o hepática avanzada</span>, <span title="diabetes with organ damage">diabetes con daño a órganos</span>, <span title="some neurological conditions">algunas condiciones neurológicas</span>, o <span title="living in nursing homes">vivir en asilos de ancianos</span>. <span title="Use shared clinical decision-making">Use la toma de decisiones clínicas compartida</span>.

2. <span title="Healthy adults 60–74 years">Adultos sanos de 60–74 años</span>: Para <span title="immunocompetent adults">adultos inmunocompetentes</span> de 60–74 años <span title="without these comorbidities">sin estas comorbilidades</span>, la ACIP <span title="indicates to use">indica usar</span> la toma de decisiones clínicas compartida. La <span title="absolute risk reduction">reducción absoluta del riesgo</span> <span title="is small">es pequeña</span> y la <span title="cost-effectiveness ratio">relación costo-efectividad</span> <span title="is lower">es menor</span>.

3. <span title="Timing">Momento</span>: <span title="Give the vaccine">Aplique la vacuna</span> <span title="right before RSV season">justo antes de la temporada de VSR</span>. En la <span title="most of the continental United States">mayor parte de los Estados Unidos continentales</span>, <span title="this is">esto es</span> <span title="late summer or early fall">a finales del verano o principios del otoño</span> <span title="August to October">(agosto–octubre)</span>.

4. <span title="Durability">Durabilidad</span>: <span title="Arexvy and Abrysvo show">Arexvy y Abrysvo muestran</span> <span title="decrease in antibody titers">disminución de títulos de anticuerpos</span>, pero <span title="good clinical efficacy">buena eficacia clínica</span> <span title="for at least">por lo menos</span> <span title="until a second RSV season">hasta una segunda temporada de VSR</span>. La ACIP <span title="does not recommend">no recomienda</span> la <span title="routine revaccination">revacunación rutinaria</span> <span title="for now">por ahora</span>.

5. <span title="Safety">Seguridad</span>: La <span title="majority of adverse events">mayoría de los eventos adversos</span> <span title="are mild or moderate">son leves o moderados</span>. <span title="Rare neurological events can occur">Pueden ocurrir raros eventos neurológicos</span> <span title="such as">como</span> el <span title="Guillain-Barré syndrome">síndrome de Guillain-Barré</span>. <span title="That's why">Por eso</span>, <span title="focus vaccination on">enfoque la vacunación en</span> adultos <span title="at higher risk">con mayor riesgo</span>, <span title="where the benefit probably outweighs">donde el beneficio probablemente supera</span> este <span title="small risk">pequeño riesgo</span>.

---
DIALOGUE

Narrator: <span title="Today, a doctor talks with a patient about the RSV vaccine">Hoy, un médico habla con un paciente sobre la vacuna contra el VSR</span>.
Physician: Hola, Sr. Chen. <span title="I want to talk with you about">Quiero hablar con usted sobre</span> la vacuna contra el VSR.
Patient: <span title="What is RSV?">¿Qué es el VSR?</span>
Physician: El VSR <span title="is a virus">es un virus</span>. <span title="It can cause serious lung infections">Puede causar infecciones pulmonares graves</span>, <span title="especially in older adults">especialmente en adultos mayores</span>.
Patient: <span title="Am I at risk?">¿Estoy en riesgo?</span>
Physician: <span title="You are 76 years old">Usted tiene 76 años</span>. Las <span title="people your age">personas de su edad</span> <span title="are at higher risk">tienen mayor riesgo</span>. La vacuna <span title="can help protect you">puede ayudar a protegerlo</span>.
Patient: <span title="Is the vaccine safe?">¿La vacuna es segura?</span>
Physician: La <span title="majority of people">mayoría de las personas</span> <span title="only have mild side effects">solo presentan efectos secundarios leves</span>, <span title="such as arm pain or fever">como dolor en el brazo o fiebre</span>. <span title="Rarely, more serious problems can occur">Rara vez pueden ocurrir problemas más serios</span>, <span title="such as nervous system disorders">como trastornos nerviosos</span>.
Patient: <span title="How many doses do I need?">¿Cuántas dosis necesito?</span>
Physician: <span title="For now, only one dose">Por ahora, solo una dosis</span>. <span title="You do not need another one this year">No necesita otra este año</span>.
Patient: <span title="When should I get it?">¿Cuándo debo ponérmela?</span>
Physician: El <span title="best time is">mejor momento es</span> <span title="at the end of summer or beginning of fall">a finales del verano o principios del otoño</span>, <span title="before RSV season starts">antes de que comience la temporada de VSR</span>.
Patient: <span title="Does the protection last?">¿La protección dura?</span>
Physician: La <span title="protection is good for at least two seasons">protección es buena por al menos dos temporadas</span>. <span title="You do not need a booster now">No necesita un refuerzo ahora</span>.
Patient: <span title="Can I wait to decide?">¿Puedo esperar para decidir?</span>
Physician: <span title="Yes, we use shared decision-making">Sí, usamos la toma de decisiones compartida</span>. <span title="I want to help you choose what is best for you">Quiero ayudarlo a elegir lo que sea mejor para usted</span>.
    </section>

    <!-- English below -->

    <details open class="card content">
      <summary>INGLÉS</summary>
STORY

In 2024–2025, RSV vaccine is mainly for adults who get the most benefit. ACIP June 2024 gives more detail on who and when to vaccinate for adults ≥60 years.

1. Clear benefit: Adults ≥75 years, and adults 60–74 years with at least one major risk condition, have the best evidence for benefit from one dose of RSV vaccine. Major risk conditions include chronic lung or heart disease, moderate–severe immunocompromise, advanced kidney or liver disease, diabetes with end-organ damage, some neurologic conditions, or living in nursing homes. Use shared clinical decision-making.

2. Healthy adults 60–74 years: For immunocompetent adults 60–74 years without these comorbidities, ACIP says use shared clinical decision-making. Absolute risk reduction is small, and cost-effectiveness is less good.

3. Timing: Give vaccine just before RSV season. In most of the continental U.S., this is late summer to early fall (August–October).

4. Durability: Arexvy and Abrysvo show waning antibody titers but good clinical efficacy into at least a second RSV season. ACIP does not advise routine revaccination now.

5. Safety: Most adverse events are mild or moderate. Rare neurologic events like GBS can occur. So focus on adults at highest risk, where benefit is more likely to be greater than this small risk.

---
DIALOGUE

Narrator: Today, a doctor talks to a patient about the RSV vaccine.
Physician: Hello, Mr. Chen. I want to talk with you about the RSV vaccine.
Patient: What is RSV?
Physician: RSV is a virus. It can cause serious lung infections, especially in older adults.
Patient: Am I at risk?
Physician: You are 76 years old. People your age have higher risk. The vaccine can help protect you.
Patient: Is the shot safe?
Physician: Most people only get mild side effects, like sore arm or fever. Rarely, there can be more serious problems like nerve trouble.
Patient: How many shots do I need?
Physician: Only one shot for now. You do not need another dose this year.
Patient: When should I get it?
Physician: The best time is late summer or early fall, before RSV season starts.
Patient: Will the shot last?
Physician: Protection is good for at least two seasons. You do not need a booster now.
Patient: Can I wait to decide?
Physician: Yes, we use shared decision-making. I want to help you choose what is best for you.
    </details>
  </main>

  <footer class="subtle">
    <div>© Dec 12, 2025 · Mezra.AI · Practica todos los días.</div>
  </footer>

  <div class="debug">EN: found</div>

  <!-- NEW: light cache-busting helper -->
  <script>
  (function() {
    // 1. Get the version tag from the URL, if present (?v=SHA...)
    var params = new URLSearchParams(window.location.search);
    var version = params.get('v');

    // 2. Read the debug indicator already inside your page
    var debug = document.querySelector('.debug');
    var debugText = debug ? debug.textContent.trim() : '';

    // 3. Heuristic: if version is missing or debug looks suspicious, force a one-time reload
    var isLikelyStale =
      !version ||
      debugText === '' ||
      debugText.indexOf('placeholder') !== -1 ||
      debugText.indexOf('not found') !== -1 ||
      debugText.length < 3;

    if (isLikelyStale) {
      if (!params.get('forceReload')) {
        params.set('forceReload', '1');
        var newUrl = window.location.pathname + '?' + params.toString();
        window.location.replace(newUrl);
      }
    }
  })();
  </script>

  <!-- Existing tooltip behavior -->
  <script>
  (function () {
    document.querySelectorAll('.content').forEach(function(container) {
      container.querySelectorAll('span[title]').forEach(function(span) {
        var text = span.textContent;
        var tip  = span.getAttribute('title');
        var btn  = document.createElement('button');
        btn.className = 'tip-word'; btn.type = 'button';
        btn.textContent = text; btn.setAttribute('data-tip', tip);
        span.replaceWith(btn);
      });
    });

    var openTip = null;
    function closeTip(){ if(openTip){ openTip.remove(); openTip = null; } }
    function showTip(target){
      closeTip();
      var tipText = target.getAttribute('data-tip') || '';
      if(!tipText) return;
      var bubble = document.createElement('div');
      bubble.className = 'tooltip';
      bubble.textContent = tipText;
      document.body.appendChild(bubble);
      var r = target.getBoundingClientRect();
      var m = 8, vw = innerWidth, vh = innerHeight;
      var rect = bubble.getBoundingClientRect();
      var tw = rect.width;
      var th = rect.height;
      var left = r.left, top = r.bottom + m;
      if (left + tw + m > vw) left = Math.max(m, vw - tw - m);
      if (left < m) left = m;
      if (top + th + m > vh) top = Math.max(m, r.top - th - m);
      bubble.style.left = left + 'px';
      bubble.style.top  = top + 'px';
      openTip = bubble;
    }

    document.addEventListener('click', function(e) {
      var word = e.target.closest('.tip-word');
      if (word){ if (openTip) closeTip(); else showTip(word); e.stopPropagation(); }
      else { closeTip(); }
    });
    document.addEventListener('touchstart', function(e) {
      if (!e.target.closest('.tip-word')) closeTip();
    }, { passive: true });
    addEventListener('scroll', closeTip, { passive: true });
    addEventListener('resize', closeTip);
    document.addEventListener('keydown', function(e) { if (e.key === 'Escape') closeTip(); });
  })();
  </script>
</body>
</html>